Skip to content


News regarding among other things the many activities the Danish Embassy in London is involved in, you find by following our social media channels:





You’re also very welcome to sign up to the embassy’s monthly newsletter that presents Danish cultural events in the UK:

Monthly newsletter

Health and Life sciences AMR Symposium postscript report

Antimicrobial Resistance (AMR) is one of the greatest international health challenges of our time. It occurs when bacteria, viruses, fungi and parasites change over time and gradually stop responding to developed medicine. The challenge of AMR is enhanced by the use of drugs meaning that the more we use these antimicrobial drugs, the less effective they become. This threatens and hinders our ability to treat infections and thus increases the risk of disease spread, illness and death.


In October 2022, the Health and Life Sciences team co-hosted a Symposium on AMR with the Novo Nordisk Foundation and the Danish Health Authority. With over 130 international participants and 19 expert speakers, the Symposium facilitated knowledge-sharing and a discussion on the challenge of AMR in an aim to identify actionable practices to solve the challenge from a One Health perspective.


The Symposium brought a number of insightful perspectives on AMR to the table in uncovering the human, environmental, societal, regulatory, veterinarian and economic side of health. These insights have now been gathered in our postscript report “Current Status on AMR from a One Health Perspective”. The report underlines a strong need for action and experts recommend continuous development of preventive measures, joint policy development and implementation targets, expanded research collaboration, and stewardship practices. It is crucial to improve clinical and diagnostic measures to inform treatment while market stimulation is needed to incentivise investments and AMR diplomacy.


The recommendations from the Symposium are as follows and can be explored further in the postscript report:

  • Policy: Promote political value and ROI from One Health investments in AMR – both human, animal, environment and broader societal determinants

  • Stewardship: Advocate for appropriate treatments through reliable diagnostics, surveillance systems and implementation of infection prevention and control

  • National Action Plans: Ensure that countries have National Action Plans on AMR with adequate funding

  • Program implementation: Facilitate adaptation and adoption of AMR interventions in different country contexts by using Implementation Research

  • Antibiotics: Ensure incentives to stimulate R&D, introduce public-private partnerships in the use of data sharing and clinical modelling, and to keep new and existing antibiotics on the market

  • Payment Models: Explore innovative payment and subscription models leveraging real world data and high degree of digitalization in society for relevant reimbursement models

Download the report here